Ioanna Triviai
Ioanna Triviai
Research Group Leader, University Clinic Hamburg Eppendorf
Verified email at uke.de
Title
Cited by
Cited by
Year
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms
S Parampalli Yajnanarayana, T Stübig, I Cornez, H Alchalby, ...
British journal of haematology 169 (6), 824-833, 2015
1072015
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
A Prestipino, AJ Emhardt, K Aumann, D O’Sullivan, SP Gorantla, ...
Science translational medicine 10 (429), 2018
872018
Impact of molecular genetics on outcome in myelofibrosis patients after allogeneic stem cell transplantation
N Kröger, V Panagiota, A Badbaran, T Zabelina, I Triviai, MMA Cruz, ...
Biology of Blood and Marrow Transplantation 23 (7), 1095-1101, 2017
632017
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
N Gagelmann, M Ditschkowski, R Bogdanov, S Bredin, M Robin, ...
Blood 133 (20), 2233-2242, 2019
402019
Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis
I Triviai, M Ziegler, U Bergholz, AJ Oler, T Stübig, V Prassolov, B Fehse, ...
Proceedings of the National Academy of Sciences 111 (23), 8595-8600, 2014
312014
Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions
K Behrens, I Triviai, M Schwieger, N Tekin, M Alawi, M Spohn, ...
Blood, The Journal of the American Society of Hematology 127 (26), 3369-3381, 2016
302016
SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell …
S Bartels, U Lehmann, G Büsche, J Schlue, M Mozer, J Stadler, I Triviai, ...
Leukemia 29 (1), 253-255, 2015
302015
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis
S Shahnaz Syed Abd Kadir, M Christopeit, G Wulf, E Wagner, ...
European journal of haematology 101 (3), 305-317, 2018
202018
Impact of molecular residual disease post allografting in myelofibrosis patients
C Wolschke, A Badbaran, T Zabelina, M Christopeit, F Ayuk, I Triviai, ...
Bone marrow transplantation 52 (11), 1526-1529, 2017
192017
High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu‐Cheney Syndrome
N Vollersen, I Hermans‐Borgmeyer, K Cornils, B Fehse, T Rolvien, ...
Journal of Bone and Mineral Research 33 (1), 70-83, 2018
152018
Patterns of cell death and cell cycle profiles of cultured WEHI 13 var fibroblasts exposed to eluates of composite resins used for direct and indirect restorations
A Bakopoulou, A Tsiftsoglou, G Galaktidou, D Markala, I Triviai, P Garefis
European journal of oral sciences 115 (5), 397-407, 2007
142007
In vitro assessment of cytotoxicity of resin-based dental restorative materials on WEHI 13 var fibroblasts.
AA Bakopoulou, IN Triviai, AS Tsiftsoglou, PD Garefis
International Journal of Prosthodontics 19 (1), 2006
122006
Assessment of bone marrow inflammation in patients with myelofibrosis: an 18 F-fluorodeoxyglucose PET/CT study
T Derlin, H Alchalby, P Bannas, S Veldhoen, I Apostolova, I Triviai, ...
European journal of nuclear medicine and molecular imaging 42 (5), 696-705, 2015
112015
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN
HFE Gleitz, AJF Dugourd, NB Leimkühler, IAM Snoeren, SNR Fuchs, ...
Blood, The Journal of the American Society of Hematology 136 (18), 2051-2064, 2020
102020
CD133 marks a stem cell population that drives human primary myelofibrosis
I Triviai, T Stübig, B Niebuhr, K Hussein, A Tsiftsoglou, B Fehse, ...
haematologica 100 (6), 768, 2015
102015
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
I Triviai, S Zeschke, J Rentel, M Spanakis, T Scherer, R Gabdoulline, ...
Leukemia 33 (1), 99-109, 2019
92019
Cytokine expression pattern in bone marrow microenvironment after allogeneic stem cell transplantation in primary myelofibrosis
K Hussein, A Stucki-Koch, H Alchalby, I Triviai, N Kröger, H Kreipe
Biology of Blood and Marrow Transplantation 22 (4), 644-650, 2016
92016
Activation of Prn‐p gene and stable transfection of Prn‐p cDNA in leukemia MEL and neuroblastoma N2a cells increased production of PrPC but not prevented …
DD Gougoumas, IS Vizirianakis, IN Triviai, AS Tsiftsoglou
Journal of cellular physiology 211 (2), 551-559, 2007
92007
The Pan-JAK inhibitor ruxolitinib impairs T-cell activation, cytokine production and proliferation in vivo and in vitro
T Stuebig, C Wolschke, H Alchalby, F Ayuk, M Heinzelmann, I Triviai, ...
Blood, The Journal of the American Society of Hematology 122 (21), 2001-2001, 2013
72013
Impact of molecular genetics on disease-free survival in myelofibrosis patients following allogeneic stem cell transplantation
N Kroeger, V Panagiota, T Zabelina, MM Araujo Cruz, R Shahswar, ...
Blood, The Journal of the American Society of Hematology 126 (23), 352-352, 2015
52015
The system can't perform the operation now. Try again later.
Articles 1–20